Safety and clinical efficacy of rapidly-generated virus-specific T cells with activity against adv, EBV, CMV, HHV6 and BK virus administered after allogeneic hematopoietic stem cell transplant

✍ Scribed by Papadopoulou, A.; Katari, U.L.; Gerdemann, U.; Tzannou, I.; Martinez, C.; Leung, K.; Carrum, G.; Gee, A.; Vera, J.; Krance, R.A.; Brenner, M.K.; Rooney, C.; Heslop, H.; Leen, A.M.

• Book ID: 122159658
• Publisher: Informa plc
• Year: 2014
• Tongue: English
• Weight: 53 KB
• Volume: 16
• Category: Article
• ISSN: 1465-3249
• DOI: 10.1016/j.jcyt.2014.01.014